EMN vs TGTX · P/E 21, rev $9.38B vs P/E 18, rev $240.3M
Eastman Chemical Company (EMN) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the EMN and TGTX stock pages for the full models.
Not investment advice.